Cozad Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Cozad Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,130	Closed	-$270K	–	391
2022 Q4	$270K	Buy	+8,130	New	+$262K	0.04%	309
2021 Q3	–	Sell	-10,760	Closed	-$239K	–	359
2021 Q2	$239K	Hold	10,760	–	–	0.04%	309
2021 Q1	$282K	Sell	10,760 -330	-3%	-$7.85K	0.05%	285
2020 Q4	$207K	Hold	11,090	–	–	0.04%	315
2020 Q3	$188K	Buy	11,090 +370	+3%	+$7.19K	0.04%	311
2020 Q2	$250K	Sell	10,720 -1,600	-13%	-$23.2K	0.05%	277
2020 Q1	$103K	Buy	+12,320	New	+$104K	0.04%	206

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cozad Asset Management's VIVO Position: Q1 2023 in Review

Cozad Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 8,130 shares — an estimated $270K sold.

Cozad Asset Management first reported a position in VIVO in Q1 2020 and held it in 7 quarters. The position peaked at $282K in Q1 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Cozad Asset Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Cozad Asset Management sold 8,130 Meridian Bioscience Inc shares in Q1 2023, an estimated $270K.
Cozad Asset Management first reported a position in Meridian Bioscience Inc in Q1 2020 and held it in 7 quarters.
Cozad Asset Management's Meridian Bioscience Inc position peaked at $282K in Q1 2021.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Cozad Asset Management's 13F filing for Q1 2023, filed 1 May 2023.